Alprazolam in the treatment of generaliz
β
G. Chouinard; L. Annable; R. Fontaine; L. Solyom
π
Article
π
1982
π
Springer
π
English
β 472 KB
In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage